Quick Answer
Uxin Ltd reported Cash and Equivalents of $3.44 million for fiscal year 2024.
Uxin Ltd Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $3.44M | -85.3% |
| 2024 | $23.34M | -74.8% |
| 2023 | $92.71M | -27.6% |
| 2022 | $128.02M | -33.5% |
| 2021 | $192.60M | -43.8% |
| 2020 | $342.50M | +0.0% |
| 2020 | $342.50M | -28.4% |
| 2019 | $478.20M | +5.1% |
| 2019 | $454.89M | -43.2% |
| 2018 | $801.00M | +174.3% |
| 2017 | $291.97M | — |
- Uxin Ltd showed a decrease of -85.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2017–2024 period, Uxin Ltd’s cash and equivalents has declined by 98.8% (from $291.97 million to $3.44 million).
- The most recent figure is from Uxin Ltd’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: